Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
New investors often wonder what to ask financial advisors. Discover essential questions that can lead to tailored advice and successful investing.
28,527 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
Geopolitical headlines drove a rush to buy the dip, yet the rebound failed to materialize for many investors. The epi...
Morgan Stanley capped redemptions at a private income fund after a surge in withdrawals, fueling a Reddit-fueled sell...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
Maybank Singapore's CEO, Alvin Lee, is steering a strategy to profit from aging demographics and cross-border wealth ...
Global worker engagement remains stuck near crisis levels, even as AI and remote work reshape the office. This story ...
Is the Trump bull market about to end, or is this a chapter in a longer market cycle? This guide blends history, data...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
Markets tremble as Iran’s leadership shift and rising oil force volatility. A JPMorgan strategist cautions against qu...
AI infrastructure is booming, but the real edge sits in data-center networking. This article explains the reason Aris...